Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$7.1 million.

  • Nuvation Bio's Change in Account Payables fell 19846.56% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 2928.33%. This contributed to the annual value of -$1.7 million for FY2024, which is 246285.71% down from last year.
  • Nuvation Bio's Change in Account Payables amounted to -$7.1 million in Q3 2025, which was down 19846.56% from $11.9 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Change in Account Payables peaked at $11.9 million during Q2 2025, and registered a low of -$7.1 million during Q3 2025.
  • In the last 3 years, Nuvation Bio's Change in Account Payables had a median value of -$164000.0 in 2023 and averaged $675272.7.
  • Over the last 5 years, Nuvation Bio's Change in Account Payables had its largest YoY gain of 361421.57% in 2024, and its largest YoY loss of 357804.88% in 2024.
  • Nuvation Bio's Change in Account Payables (Quarter) stood at -$164000.0 in 2023, then plummeted by 3578.05% to -$6.0 million in 2024, then decreased by 17.03% to -$7.1 million in 2025.
  • Its Change in Account Payables was -$7.1 million in Q3 2025, compared to $11.9 million in Q2 2025 and $4.2 million in Q1 2025.